| Use of complementary and alternative medicine by children in Europe: published data and expert perspectives TJ Zuzak, J Boňková, D Careddu, M Garami, A Hadjipanayis, J Jazbec, ... Complementary therapies in medicine 21, S34-S47, 2013 | 189 | 2013 |
| Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria K Tachkov, K Mitov, Y Koleva, Z Mitkova, M Kamusheva, M Dimitrova, ... PloS one 15 (5), e0232815, 2020 | 49 | 2020 |
| Pharmaceutical regulation in Central and Eastern European countries: a current review P Kawalec, T Tesar, L Vostalova, P Draganic, M Manova, A Savova, ... Frontiers in pharmacology 8, 892, 2017 | 45 | 2017 |
| Comparative price analysis of biological products for treatment of rheumatoid arthritis M Manova, A Savova, M Vasileva, S Terezova, M Kamusheva, D Grekova, ... Frontiers in Pharmacology 9, 1070, 2018 | 39 | 2018 |
| Reimbursement legislations and decision making for orphan drugs in central and eastern European countries KP Malinowski, P Kawalec, W Trabka, M Czech, G Petrova, M Manova, ... Frontiers in pharmacology 10, 487, 2019 | 28 | 2019 |
| Comparative analysis of legislative requirements about patients' access to biotechnological drugs for rare diseases in Central and Eastern European Countries M Kamusheva, M Manova, AT Savova, GI Petrova, K Mitov, A Harsányi, ... Frontiers in pharmacology 9, 795, 2018 | 18 | 2018 |
| Orphan medicinal products’ access to the Bulgarian pharmaceutical market–challenges and obstacles M Kamusheva, K Tachkov, G Petrova, A Savova, M Manova Expert Opinion on Orphan Drugs 6 (2), 95-104, 2018 | 16 | 2018 |
| Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe KP Malinowski, P Kawalec, W Trąbka, C Sowada, G Petrova, M Manova, ... Orphanet journal of rare diseases 15, 1-13, 2020 | 15 | 2020 |
| Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria M Russel-Szymczyk, V Valov, A Savova, M Manova BMC endocrine disorders 19, 1-10, 2019 | 14 | 2019 |
| Regional differences in diabetic patients' pharmacotherapy in Bulgaria. V Valov, M Doneva, AM Borisova, T Tankova, M Czech, M Manova, ... European Review for Medical & Pharmacological Sciences 18 (11), 2014 | 13 | 2014 |
| Cost of hospitalizations due to microvascular and macrovascular complications in type 1 and type 2 diabetic patients in Bulgaria M Dimitrova, M Doneva, V Valov, S Yordanova, M Manova, A Savova, ... Biotechnology & Biotechnological Equipment 29 (4), 805-813, 2015 | 12 | 2015 |
| Utilization and price trends in some reimbursed cardiovascular medicines M Manova, A Stoimenova, A Savova, P Peikov, G Petrova Biotechnology & Biotechnological Equipment 25 (2), 2424-2431, 2011 | 12 | 2011 |
| Liraglutide vs. exenatide in combination with metformin and/or sulfonylurea therapy in type 2 diabetes mellitus therapy in Bulgaria: a modelling study G Petrova, A Ivanova, M Czech, V Valov, W Wrona, M Niewada, A Savova Comptes rendus de l’Academie bulgare des Sci 64, 1507-1514, 2011 | 12 | 2011 |
| Historical overview of regulatory framework development on pricing and reimbursement of medicines in Bulgaria M Vassileva, M Kamusheva, M Manova, A Savova, K Tachkov, G Petrova Expert review of pharmacoeconomics & outcomes research 19 (6), 733-742, 2019 | 11 | 2019 |
| Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment A Zemplényi, K Tachkov, L Balkanyi, B Németh, ZI Petykó, G Petrova, ... Frontiers in Public Health 11, 1088121, 2023 | 10 | 2023 |
| Pharmaceutical biotechnology education in the pharmacy curriculum at European Universities A Savova, K Mitov, A Stoimenova, M Manova, G Petrova Biotechnology & Biotechnological Equipment 26 (4), 3187-3191, 2012 | 10 | 2012 |
| Generic policy in Bulgaria: a policy of failure or success? A Stoimenova, S Penkov, A Savova, M Manova, G Petrova Biotechnology & Biotechnological Equipment 30 (5), 1031-1037, 2016 | 9 | 2016 |
| Comparative analysis of the cost of insulin treated patients in Bulgaria M Doneva, V Valov, AM Borisova, T Tankova, A Savova, M Manova, ... Biotechnology & Biotechnological Equipment 27 (2), 3748-3752, 2013 | 9 | 2013 |
| The health related quality of life for kidney transplant patients in Bulgaria—a pilot study S Georgieva, M Kamusheva, D Lakić, K Mitov, A Savova, G Petrova Biotechnology & Biotechnological Equipment 26 (3), 3062-3065, 2012 | 9 | 2012 |
| Quality management in pharmaceutical procurement: Most frequent non-conformities in pharmaceutical wholesalers in Bulgaria A Stoimenova, A Savova, M Manova, G Petrova Biotechnology & Biotechnological Equipment 27 (5), 4193-4196, 2013 | 8 | 2013 |
